Daniel Lorentzen
08/2003 - 06/2009
Chief IP Counsel, Genus PLC
A Novel Antimicrobial Mechanism of Cystic Fibrosis and Healthy Airways
Biography
Advisor: William Nauseef
IP Counsel
Genus Plc.
